Literature DB >> 2330387

Peripheral catecholamine levels and the symptoms of anxiety: studies in patients with and without pheochromocytoma.

M N Starkman1, O G Cameron, R M Nesse, T Zelnik.   

Abstract

We studied the correlation of plasma and urinary epinephrine (E) and norepinephrine (NE) levels with anxiety symptoms in three patient groups: 1) pheochromocytoma (PH+) (n = 17); 2) hypertensives with elevated catecholamine levels shown not to have a PH (PH-) (n = 25); and 3) patients with panic disorder (PD) (n = 23). Structured interviews and four self-rated anxiety scales were used: the SCL-90R Anxiety and Phobic Anxiety scales, and the Spielberger State/Trait Anxiety Inventories. The SCL-90R Somatization scale (which measures 12 somatic symptoms) was also utilized. None of the PH+ patients met DSM-III criteria for PD. Two met criteria for generalized anxiety disorder (GAD). Of the PH- patients, two had PD, two had GAD, and three had both. Urinary and plasma E did not show significant positive correlations with any of the four anxiety scales in any of the three patient groups. In both the PH+ and PH- groups, E was significantly correlated with the SCL-90R Somatization scale. NE was not significantly correlated with any of the four anxiety scales in the PH+ group. In contrast, in the PH- group, plasma NE was significantly correlated with anxiety on all anxiety scales (r = +0.55 to +0.77, p less than 0.05). Furthermore, in the PH- group, plasma NE was significantly correlated with those items of the SCL-90R Anxiety scale measuring the cognitive rather than the noncognitive symptoms of anxiety. In the PD group as well, plasma NE showed a significant correlation with the SCL-90R Anxiety Scale (r = +0.67, p less than 0.05). Taken together, our observations suggest that: 1) the effects of catecholamines in the periphery derived from a source independent of nervous system control (such as a PH) are not sufficient to elicit an anxiety disorder meeting DSM-III criteria; and 2) in patients without an autonomous source of peripheral catecholamines, NE in the periphery results from sympathetic nervous system activation and probably reflects, rather than causes, anxiety.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2330387     DOI: 10.1097/00006842-199003000-00001

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  10 in total

1.  Fetal response to induced maternal emotions.

Authors:  Miyuki Araki; Shota Nishitani; Keisho Ushimaru; Hideaki Masuzaki; Kazuyo Oishi; Kazuyuki Shinohara
Journal:  J Physiol Sci       Date:  2010-02-19       Impact factor: 2.781

Review 2.  Impact of maternal stress, depression and anxiety on fetal neurobehavioral development.

Authors:  Michael T Kinsella; Catherine Monk
Journal:  Clin Obstet Gynecol       Date:  2009-09       Impact factor: 2.190

3.  Symptom-dependent cut-offs of urine metanephrines improve diagnostic accuracy for detecting pheochromocytomas in two separate cohorts, compared to symptom-independent cut-offs.

Authors:  Yoon Young Cho; Kee-Ho Song; Young Nam Kim; Seong Hee Ahn; Hyeonmok Kim; Sooyoun Park; Sunghwan Suh; Beom-Jun Kim; Soo-Youn Lee; Sail Chun; Jung-Min Koh; Seung Hun Lee; Jae Hyeon Kim
Journal:  Endocrine       Date:  2016-08-02       Impact factor: 3.633

4.  Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study.

Authors:  J M Teixeira; N M Fisk; V Glover
Journal:  BMJ       Date:  1999-01-16

5.  The effects of maternal anxiety prior to amniocentesis on uterine and fetal umbilical blood flow.

Authors:  Eray Calışkan; Sebiha Ozkan; Yiğit Cakıroğlu; Ozden Yalçınkaya; Aslıhan Polat; Aydın Corakçı
Journal:  J Turk Ger Gynecol Assoc       Date:  2009-09-01

6.  Relationships Between Catecholamine Levels and Stress or Intelligence.

Authors:  Ye-Ha Jung; Joon Hwan Jang; Dasom Lee; Yoobin Choi; Soo-Hee Choi; Do-Hyung Kang
Journal:  Neurochem Res       Date:  2019-03-18       Impact factor: 3.996

7.  Biomarkers of a five-domain translational substrate for schizophrenia and schizoaffective psychosis.

Authors:  Stephanie Fryar-Williams; Jörg E Strobel
Journal:  Biomark Res       Date:  2015-02-06

8.  Biomarker Case-Detection and Prediction with Potential for Functional Psychosis Screening: Development and Validation of a Model Related to Biochemistry, Sensory Neural Timing and End Organ Performance.

Authors:  Stephanie Fryar-Williams; Jörg E Strobel
Journal:  Front Psychiatry       Date:  2016-04-14       Impact factor: 4.157

9.  Glioma induced alterations in fecal short-chain fatty acids and neurotransmitters.

Authors:  Antonio Dono; Anthony Patrizz; Ryan M McCormack; Nagireddy Putluri; Bhanu P Ganesh; Balveen Kaur; Louise D McCullough; Leomar Y Ballester; Yoshua Esquenazi
Journal:  CNS Oncol       Date:  2020-06-30

Review 10.  Prenatal maternal stress and offspring aggressive behavior: Intergenerational and transgenerational inheritance.

Authors:  Ngala Elvis Mbiydzenyuy; Sian Megan Joanna Hemmings; Lihle Qulu
Journal:  Front Behav Neurosci       Date:  2022-09-23       Impact factor: 3.617

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.